Hippuric Acid

Hippuric Acid

SCHEMBL1609915

C1N2CN3CN1CN(C2)C3.C1N2CN3CN1CN(C2)C3.O=C(O)C(O)c1ccccc1.O=C(O)CNC(=O)c1ccccc1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TPH1TPH2

The experimentally established mechanism targets of Hippuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ LMNA P02545 4/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ GPR139 Q6DWJ6 1/20 0.47
▸ EPHX2 P34913 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ SLC22A6 Q4U2R8 1/20 0.44
▸ SLC22A8 Q8TCC7 1/20 0.44
▸ SLC6A9 P48067 2/20 0.43
▸ SLC6A5 Q9Y345 2/20 0.43
▸ PTPRC P08575 2/20 0.43
▸ CTSL P07711 1/20 0.43
▸ PTPN13 Q12923 1/20 0.43
▸ OPRK1 P41145 1/20 0.43
▸ GAA P10253 1/20 0.42
▸ HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hippuric Acid SCHEMBL31448705 0.92 LMNA (0.58) NPC1RAB9ASMN1; SMN2LMNAMAPK1
Hippuric Acid SCHEMBL2405067 0.87 KDM4E (0.56) NPC1RAB9ASMN1; SMN2LMNAMAPK1
Hippuric Acid SCHEMBL3029 0.87 KDM4E (0.56) NPC1RAB9ASMN1; SMN2LMNAMAPK1
Hippuric Acid SCHEMBL2464569 0.83 KDM4E (0.56) RAB9ASMN1; SMN2MAPK1GPR139KDM4E
Mandelic Acid SCHEMBL3645 0.81 LMNA (0.75) NPC1SMN1; SMN2LMNAMAPK1KDM4E
Mandelic Acid SCHEMBL9747772 0.81 LMNA (0.75) NPC1SMN1; SMN2LMNAMAPK1KDM4E
Mandelic Acid SCHEMBL388417 0.79 LMNA (0.72) NPC1SMN1; SMN2LMNAMAPK1KDM4E
Hippuric Acid SCHEMBL428479 0.77 GAA (0.68) NPC1RAB9ASMN1; SMN2LMNAGPR139
SCHEMBL22030672 0.77 GAA (0.68) NPC1RAB9ASMN1; SMN2LMNAGPR139
Hippuric Acid SCHEMBL7486 0.77 GAA (0.68) NPC1RAB9ASMN1; SMN2LMNAGPR139

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110087009-A1 PROCESS FOR THE CONTROLLED PRODUCTION OF ORGANIC PARTICLES YUN SUNG LAI JIMMY 2011-04-14 — — US disclosed
US-7875295-B2 High shear precipitation; faster, higher yield of microparticles or nanoparticles NANOMATERIALS TECHNOLOGY PTE LTD (SG) 2011-01-25 — — US disclosed
US-20080212402-A1 Process for the controlled production of organic particles YUN SUNG LAI JIMMY 2008-09-04 — — US disclosed
EP-0935460-B1 TASTE MASKED PHARMACEUTICAL COMPOSITIONS FAULDING F H & CO LTD (AU) 2004-11-10 — — EP disclosed
US-20040191319-A1 Process for the controlled production of organic particles NMT PHARMACEUTICALS PTE LTD (SG) 2004-09-30 — — US disclosed
US-20030064108-A1 TASTE MASKED PHARMACEUTICAL COMPOSITIONS FH FAULDING & CO. LIMITED (AU) 2003-04-03 — — US disclosed
WO-2002089970-A1 PROCESS FOR THE CONTROLLED PRODUCTION OF ORGANIC PARTICLES NANOMATERIALS TECHNOLOGY PTE LTD (SG) 2002-11-14 — — WO disclosed
EP-0935460-A4 TASTE MASKED PHARMACEUTICAL COMPOSITIONS FAULDING F H & CO LTD (AU) 1999-12-22 — — EP disclosed
EP-0935460-A1 TASTE MASKED PHARMACEUTICAL COMPOSITIONS F.H. FAULDING & CO. LIMITED (AU) 1999-08-18 — — EP disclosed
WO-1998047493-A1 TASTE MASKED PHARMACEUTICAL COMPOSITIONS F.H. FAULDING & CO. LIMITED (AU) 1998-10-29 — — WO disclosed
Send feedback